Pregabalin vs. Gabapentin on Reducing Opioid Usage
Status:
Recruiting
Trial end date:
2022-04-12
Target enrollment:
Participant gender:
Summary
This is a single-center, randomized, open-label, Phase 4 clinical trial investigating the
efficacy of multiple-dose administrations of Pregabalin or Gabapentin in combination with
traditional opioid pain medications to decrease the amount of opioid pain medication usage in
single-system orthopedic trauma patients.